Search Results 1-10 of 19330 for Mt
The multitarget stool DNA (mt-sDNA) test showed more than 95% specificity in a cross-sectional study of 45- to 49-year-old patients at average risk for ...
This study is a Phase 1 multicenter, open-label study evaluating the safety and efficacy of escalating doses of MT-401-OTS in 2 participant populations.
MEDIA ADVISORY: Mayo Clinic Everest Team Leaves. Monday April 16th @ 3:30 p.m. Rochester, MN Airport. Mayo Clinic's research team of physiologists leave for ...
The main purpose of this study is to evaluate the safety and tolerability of MT-0169 and establish the MTD (maximum tolerated dose)/ RP2D (recommended phase 2 ...
Extreme athletes who can summit Mt. Everest have more in common than you might think with people who suffer from heart failure. Mayo Clinic researchers say ...
Warrington NV, Shetty A, Heller MT, Thompson C, Tan N, Elsayes KM, Revzin M, Zulfiqar M. Oncologic pitfalls and mimics in the abdomen and pelvis.
Greater rates of polyp diagnosis were observed when a proceduralist was aware they were doing a colonoscopy after a positive mt-sDNA test, compared with rates ...
The primary purpose of this study is to assess the sensitivity for colorectal cancer (CRC) and specificity of the mt-sDNA 2.0 test. Participation eligibility.
Did They Know What They Were Getting Themselves Into, Going To Mt. Everest ... Montana State University climbers. The medical group will be back in the ...
... MT-3921 to placebo in treatment of subjects with acute traumatic cervical spinal cord injury. The study assesses the effect of MT-3921 on sensory and motor ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.